Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Sep 15:71:102869.
doi: 10.1016/j.amsu.2021.102869. eCollection 2021 Nov.

Curing the incurable: A case of refractory vasospastic angina

David Song  1 , Mohamed Abdelghffar  1 , Tasur Seen  1 , Andrew Kim  2 , XiongBin Lin  1 , Saad Ahmad  1 , Talal Almas  3 , Julie Kanevsky  1
Affiliations
Case Reports

Curing the incurable: A case of refractory vasospastic angina

David Song et al. Ann Med Surg (Lond). .

Abstract

Vasospastic angina (VSA) is the spasm of coronary arteries causing transient myocardial ischemia. VSA is commonly managed with antispasmodic medications including calcium-channel blockers (CCB) and nitrates. When vasospasm is refractory to conventional medications, unconventional treatment modalities may be used for symptomatic relief (Tandon et al., 2019 Feb) [1]. There are several mediators of vasospasm, with serotonin playing a major role. Serotonin is a product of platelet aggregation and has multiple effects on the endothelium, which forms the basis of an unconventional treatment modality that may be used for symptomatic relief of VSA. In this case, a 44 year old female with a history of coronary artery disease (CAD) status post coronary artery bypass graft (CABG) with recent drug-eluting stent (DES) placement was admitted for shortness of breath and chest pain, found to have a positive stress echocardiogram (Echo), and had unremarkable coronary angiography. Given persistent symptoms while on optimal medical therapy and with negative coronary angiography, the diagnosis of refractory VSA was made. Patient was started on a serotonin receptor blocker with improvement of her symptoms.

Keywords: Coronary artery disease; Serotonin receptor inhibitor; Vasospastic angina.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
Coronary angiography with ergonovine challenge showing spasm of left anterior descending (LAD).
See this image and copyright information in PMC

References

    1. Tandon Varun, Christian M., Mosebach, Kumar Manish, Joshi Saurabh. vol. 11. 2019 Feb. (Refractory Vasospastic Angina: when Typical Medications Don't Work). 2. - DOI - PMC - PubMed
    1. Picard Fabien, Sayah Neila. Vasospastic angina: a literature review of current evidence. Archives of Cardiovascular Diseases. 2019;112(Issue 1):44–55. doi: 10.1016/j.acvd.2018.08.002. ISSN 1875-2136. - DOI - PubMed
    1. Prinzmetal Myron, Kennamer Rexford. Angina pectoris I. A variant form of angina pectoris: preliminary report. Am. J. Med. 1959 Sep;27:375–388. doi: 10.1016/0002-9343(59)90003-8. - DOI - PubMed
    1. Agha R.A., Franchi T., Sohrabi C., Cathew G., for the Scare Group The SCARE 2020 guideline: updating consensus surgical CAse REport (SCARE) guidelines. Int. J. Surg. 2020;84:226–230. - PubMed
    1. Ibanez B., James S., Agewall S. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur. Heart J. 2017;39:119–177. doi: 10.1093/eurheartj/ehx393. 2018. - DOI - PubMed

Publication types